Clinical outcomes after implantation of bioprosthetic valves in adults with congenital heart disease [PDF]
Background: Bioprosthetic valves are frequently implanted in adults with congenital heart disease (CHD), but comprehensive data on bioprosthetic valve longevity and outcomes across all valve positions are lacking.
Andrea R. Hsu +10 more
doaj +3 more sources
Case report: Transapical transcatheter double valve-in-valve replacement of degenerated aortic and mitral bioprosthetic valves with limited radiopaque landmarks [PDF]
A 67-year-old male patient who had undergone double valve replacement 11 years before presented with severe dyspnea to our department. The bioprosthetic aortic and mitral valves have failed. Because of the high risk of redo surgery.
Jiawei Zhou, Yuehuan Li, Haibo Zhang
doaj +4 more sources
Electrosurgical Leaflet Modification to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement in Failing Native and Bioprosthetic Valves. [PDF]
Background In patients with high-risk anatomy, transcatheter aortic valve replacement (TAVR) risks coronary obstruction which is associated with high morbidity and mortality.
Rogers T +26 more
europepmc +2 more sources
Biomechanical analysis of novel leaflet geometries for bioprosthetic valvesCentral MessagePerspective [PDF]
Objectives: Although bioprosthetic valves have excellent hemodynamic properties and can eliminate the need for lifelong anticoagulation therapy, these devices are associated with high rates of reoperation and limited durability.
Pearly K. Pandya, BS +3 more
doaj +2 more sources
Long‐Term Outcomes of Patients Undergoing Aortic Root Replacement With Mechanical Versus Bioprosthetic Valves: Meta‐Analysis of Reconstructed Time‐to‐Event Data [PDF]
Background An aspect not so clear in the scenario of aortic surgery is how patients fare after composite aortic valve graft replacement (CAVGR) depending on the type of valve (bioprosthetic versus mechanical).
Michel Pompeu Sá +8 more
doaj +2 more sources
In the recent years, there has been significant transformation in the management of valvular heart disease (VHD), as a result of new minimally invasive technologies, such as the transcatheter aortic valve implantation (TAVI).
Rachel Ryu PharmD, BCPS +1 more
doaj +2 more sources
Mechanical versus bioprosthetic valves in patients on dialysis. [PDF]
Background The aim of this study is to evaluate the outcomes of bioprosthetic versus mechanical valves in patients on dialysis. Methods All patients who underwent aortic (AVR) or mitral valve replacement (MVR) at a single institution from 2011-2017 ...
Chan PG +4 more
europepmc +2 more sources
Bioprosthetic Valve Thrombosis
Degenerative valve disease is on the rise with greater than 100,000 valve operations performed in the US alone per year. The majority of those procedures employ tissue bioprostheses to avoid the attendant risk of anticoagulation, especially in the elderly. Though traditionally this approach has been considered a superior option to avoid anticoagulation,
Bassam Omar +2 more
exaly +4 more sources
Outcomes of mechanical and bioprosthetic surgical valve replacements in egypt: evidence from a narrative review and experts’ survey [PDF]
Background Selecting between mechanical and bioprosthetic valves depends on multiple clinical and patient-specific criteria. This study aims to compare mechanical and bioprosthetic valve replacement outcomes in Egypt to support evidence-informed decision-
Mohamed El Fiky +12 more
doaj +2 more sources
Background There is an ever-growing number of patients requiring aortic valve replacement (AVR). Limited data is available on the long-term outcomes and structural integrity of bioprosthetic valves in younger patients undergoing surgical AVR. Methods The
Bart Meuris +22 more
doaj +2 more sources

